Fact CheckerSign in

NCT07578155Completed

Validation of Accexible Screening and Self-Administered Activities for Emotional Well-Being in a University Hospital (UaDEC)

Validation of the Accexible Screening and Self-administered Activities for Emotional Well-being in a University Hospitalpopulation (UaDEC)

Source: ClinicalTrials.gov · Last updated 11 May 2026

Brief summary (registry, in English)

Major depressive disorder (MDD) and anxiety are increasingly prevalent among university student populations, yet early detection remains reliant on psychometric instruments tied to diagnostic criteria (e.g., PHQ-9, GAD). Emerging evidence suggests that depression affects both the acoustic properties and content of speech, making speech analysis a promising candidate as a digital biomarker for early screening. This study evaluates the validity of acceXible, a speech-based machine learning platform, for the detection and monitoring of depression and anxiety in the student population of the Universidad Autónoma de Coahuila (UAdeC), Mexico. AcceXible captures spontaneous speech through open-ended interview tasks and applies automated acoustic and linguistic analysis. The primary objective is to evaluate the validity of the acceXible spontaneous speech analysis system for depression and anxiety screening, assessed against the PHQ and GAD scales as reference standards. Secondary objectives include examining associations between speech-derived variables and other study measures, evaluating participant engagement with digital mental health resources, assessing user satisfaction with the platform, and analyzing longitudinal changes in scores across follow-up assessments.

Status (registry)
Completed
Study type
Observational
Enrollment
902 (actual)
First submitted
5 May 2026
Start date
19 Mar 2024
Primary completion date
4 Apr 2025
Lead sponsor
Accexible
Diseases
Depression
NCT number
NCT07578155

What you commit to

  • Study type: Observational
  • Participants enrolled: 902
  • From 19 Mar 2024 to the primary completion date, 4 Apr 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Sensory impairment (visual or auditory)

Other

  • Refusal to participate
  • Psychomotor agitation

Who the study is looking for

  • Provision of voluntary written informed consent
  • Age 16-25 years
  • Current enrollment at BUAP
  • Spanish language proficiency
  • Access to a mobile device with internet connectivity
  • Ability to understand and follow basic acceXible usage instructions

Age in the registry: 16 years to 25 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Universidad Autónoma de Coahuila (UAdeC)
Coordinator of this site? Confirm its status
SaltilloMexicoUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.